Investigational Drug Information for Firibastat
✉ Email this page to a colleague
What is the drug development status for Firibastat?
Firibastat is an investigational drug.
There have been 5 clinical trials for Firibastat.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 5th 2021.
The most common disease conditions in clinical trials are Hypertension, Kidney Failure, Chronic, and Ventricular Dysfunction, Left. The leading clinical trial sponsors are Quantum Genomics SA, PRA Health Sciences, and Quotient Sciences.
There are three US patents protecting this investigational drug and fifty-six international patents.
Summary for Firibastat
| US Patents | 3 |
| International Patents | 56 |
| US Patent Applications | 3 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2021-08-05) |
| Vendors | 26 |
Recent Clinical Trials for Firibastat
| Title | Sponsor | Phase |
|---|---|---|
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) | PRA Health Sciences | Phase 3 |
| Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) | Quantum Genomics SA | Phase 3 |
| Firibastat in Treatment-resistant Hypertension | Quantum Genomics SA | Phase 3 |
Clinical Trial Summary for Firibastat
Top disease conditions for Firibastat
Top clinical trial sponsors for Firibastat
US Patents for Firibastat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Firibastat | ⤷ Try a Trial | Derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same | Institute National de la Sante et de la Recherche Medicale (Inserm) (Paris Cedex, FR) | ⤷ Try a Trial |
| Firibastat | ⤷ Try a Trial | Method for the preparation of (3S, 3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (Paris, FR) | ⤷ Try a Trial |
| Firibastat | ⤷ Try a Trial | Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) | QUANTUM GENOMICS (Massy, FR) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Firibastat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Firibastat | Austria | AT455097 | 2023-08-06 | ⤷ Try a Trial |
| Firibastat | Canada | CA2533432 | 2023-08-06 | ⤷ Try a Trial |
| Firibastat | Cyprus | CY1109950 | 2023-08-06 | ⤷ Try a Trial |
| Firibastat | Germany | DE602004025119 | 2023-08-06 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
